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315Abstracts
PROGRESS trial. Cost for stroke-related hospitalization
and re-hospitalization, rehabilitation, nursing home, 
and ambulatory care derived from national data and 
published literature. Historical cost data was inﬂation-
adjusted to 2001 values, savings in the 2nd and 3rd year
were discounted at 3%, and health care CPI inﬂation-
adjusted at 4.7%. Treatment and control group (no SSP
medication) were replenished after the 1st and 2nd year
in equal numbers with newly SSP eligible patients (new
ﬁrst stroke survivors of the HMO population). Drug
prices were deﬁned as WAC-20% plus $5 co-pay. Sensi-
tivity analysis on stroke incidences, selected transition
probabilities and costs will be presented. RESULTS: SSP
with perindopril/indapamide saved 28 lives and 110
strokes in the ﬁrst year (after 3 years 169 and 325 respec-
tively). Treatment achieved a net beneﬁt of $803,000 in
the ﬁrst, $3,267,253 in the second and $6,207,814 by the
third year. The cost per stroke prevented was $24,648 and
$47,412 per death averted over the three year period.
CONCLUSIONS: SSP with perindopril/indapamid saves
lives and healthcare costs.
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OBJECTIVES: To estimate the rate of hospitalizations
due to cardiovascular disease and other causes following
an acute atherothrombotic stroke and the associated
costs. METHODS: We evaluated hospitalization rates
(cumulative number divided by the patient time in a given
period) following a diagnosis of acute stroke using the
health care records of residents of Saskatchewan, Canada
who were diagnosed between 1990–1995. Data on
patient characteristics and medical history were available
from January 1980 and follow-up was complete to
December 2000. Costs (2002 Canadian dollars) were also
estimated. Reasons for hospitalization were classiﬁed on
the basis of primary diagnosis, into atherothrombotic
(stroke, TIA, myocardial infarction, angina, or other car-
diovascular disease), gastrointestinal (GI) bleeding and
other. RESULTS: The 18,704 patients with stroke (48%
male) tended to be elderly (mean age 70.5 years). Nearly
two-thirds died during follow-up. At least 1 hospitaliza-
tion occurred in 13,952 (72.7%), a hazard of 36.2/100
person years and those hospitalized had 3.9 admissions
on average. Atherothrombotic causes were most frequent
(82.4%), the majority were stroke and TIA (53.2%), but
length of stay was longest for GI bleeds (mean 17.1 days
vs 16.1 for atherothrombotic disease). The admission
rates due to atherothrombotic disease were 3 times higher
in the month following stroke than after the ﬁrst year;
and higher with age greater than 65 years (hazard ratio
1.8, 95% CI 1.69–1.83), diabetes (1.7, 1.62–1.86), 
atrial ﬁbrillation (2.1, 1.96–2.30), hypertension (1.8
1.65–1.86), heart failure (2.1, 1.97–2.21) and prior
atherothrombotic events (1.2, 1.17–1.32). Atherothrom-
botic hospitalizations accrue costs between $442 per
patient per month in the ﬁrst month to $39 per patient
per month after 5 years. CONCLUSIONS: Patients 
surviving a stroke are frequently readmitted, mostly for
atherothrombotic problems, and these events accrue 
substantial costs, especially early on in the course 
post-stroke.
PCV25
AN INVESTIGATION OF THE CARE NEEDS
AFTER ACUTE ISCHEMIC STROKE: AN
ANALYSIS OF THE DATA COLLECTED IN 
THE ERLANGEN STROKE PROJECT
Ward AJ1, Payne KA2, Caro J1, Heuschmann PL3,
Kolominsky-Rabas P3
1Caro Research Institute, Concord, MA, USA; 2Caro Research
Institute, Montreal, QC, Canada; 3University of Erlangen,
Erlangen, Germany
OBJECTIVE: To determine the functional outcome, loca-
tion of care and economic consequences three months 
following hospitalization for ﬁrst ischemic stroke.
METHODS: As part of the Erlangen Stroke Project
(ESPro), information was collected on patients diagnosed
as having a stroke between April 1994 and March 1996.
Barthel Index (BI), Functional Independence Measure
(FIM) and location of care were determined three months
after the stroke. A subset of eight items from the FIM was
used to deﬁne patients as independent or dependent on
caregivers. BI scores three months after the stroke were
divided into three categories low (0–55), medium (60–90)
and high (95–100). Data collected about health and social
services used by these patients were combined with esti-
mates of costs for these services in Germany. Costs were
estimated in 2000 DM (1 = $ 0.53 USD, €0.51), undis-
counted. RESULTS: Information was recorded on 379
patients, half of whom had not fully recovered at 3
months (27% medium BI, 24% in low category). The
majority (79%) was residing in the community, 43%
remained dependent but 61% of them still returned to the
community. Cumulative costs of care over 3 months for
institutionalized patients with high BI were DM35, 100,
and with medium BI DM55,000; about 1.5 fold those of
patients in the same category residing in the community.
Costs for patients with low BI were higher whether in 
the community (DM51,600) or in institutional care
(DM53,400). CONCLUSION: Many patients were left
with a level of disability that required a substantial
amount of support from caregivers. In Germany, location
of care has an impact on the economic consequences at
higher levels of BI only.
